Immunogenicity of chimeric MUC1-HER2 vaccine against breast cancer in mice

OBJECTIVE(S): Breast cancer is one of the most common cancers in the world and is on the increase. MUC1 and HER2 as tumor-associated antigens (TAAs) are abnormally expressed to some extent in 75–80% of breast cancers. In our present research, a novel chimeric MUC1-HER2 (HM) protein was designed and...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Iran J Basic Med Sci
Autors principals: Gheybi, Elaheh, Salmanian, Ali Hatef, Fooladi, Abbas Ali Imani, Salimian, Jafar, Hosseini, Hamideh Mahmoodzadeh, Halabian, Raheleh, Amani, Jafar
Format: Artigo
Idioma:Inglês
Publicat: Mashhad University of Medical Sciences 2018
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5776432/
https://ncbi.nlm.nih.gov/pubmed/29372033
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.22038/IJBMS.2017.25686.6335
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars